Zusammenfassung Hintergrund Medikamentöse Therapiestrategien zur Behandlung der
rheumatoiden Arthritis sind entscheidend für den Langzeitverlauf. Sie dienen dem Ziel …

Objectives A treat-to-target (T2T) strategy has been shown to be superior to usual care in
rheumatoid arthritis (RA), but the optimal target remains unknown. Targets are based on a …

Hintergrund: Medikamentöse Therapiestrategien zur Behandlung der rheumatoiden Arthritis
sind entscheidend für den Langzeitverlauf. Sie dienen dem Ziel, durch frühe und …

Objective To study juvenile idiopathic arthritis (JIA) long‐term outcomes in relation to the
time of initiation of biologic disease‐modifying antirheumatic drug (bDMARD). Methods …

Despite its inclusion in current treatment recommendations, adherence to the treat-to-target
strategy (T2T) is still poor. Among the issues are the definition (s) of target, especially the …

Objectives To explore the effect of mindfulness interventions in improving outcomes for
patients with rheumatoid arthritis. Methods Following the collective strategy of Cochrane …

Janus kinases (JAKs) play an important role in intracellular signaling for multiple cytokines
in the pathogenesis of RA. Baricitinib is an oral, selective JAK 1 and 2 inhibitor which has …

A panel of European experts was convened to establish consensus on a treat-to-target
strategy in osteoporosis. Panellists agreed that the ultimate goals of treating osteoporosis …

Background The emphasis on treating rheumatoid arthritis (RA) intensively reduces disease
activity but its impact in routine care is uncertain. We evaluated temporal changes in disease …

Objectives To examine associations between function, quality of life and structural outcomes
in patients achieving remission vs low disease activity in early RA. Methods Demographic …